Recently, Taizhou Ruisheng Medical Technology Co., Ltd. (hereinafter referred to as "Ruisheng Medical")—a national-level "Little Giant" enterprise specializing in a niche market with strong high-tech capabilities—made significant appearances at three of the world's premier medical exhibitions: MEDICA (Germany), FIME (USA), and Arab Health (Dubai). By showcasing its full range of high-end functional medical dressings and leveraging technological innovation and superior quality, the company actively expanded its presence in Europe, North America, the Middle East, and beyond, fully demonstrating the international competitiveness of Chinese medical dressing enterprises.
A Triple-Exhibition Launch: Accelerating Global Expansion
As an industry leader with over thirty years of experience in the medical dressing sector, Ruisheng Medical participated in these three major exhibitions under the theme of being a "Global Provider of Wound Care Solutions." The company presented a core product portfolio covering a complete range of high-end dressings—including calcium alginate, hydrocolloid, silicone foam, silver-loaded antimicrobial, and Manuka honey dressings—designed to meet clinical needs across the entire wound healing cycle.
**MEDICA (Germany):** At MEDICA, the world's largest and most influential medical industry event, Ruisheng Medical showcased a full product line holding EU CE certification, with a special focus on flagship products such as silver-loaded calcium alginate dressings and non-adherent acetate dressings. Boasting core advantages—including a 99.99% antimicrobial rate, 7-day sustained antimicrobial action, and high-efficiency exudate absorption—these products attracted hospitals, distributors, and buyers from across Europe for in-depth discussions, further solidifying Ruisheng Medical's leading position in the European market.
**FIME (USA):** Targeting the high-end North American medical market, Ruisheng Medical showcased products that have obtained US FDA 510(k) clearance, such as silver-loaded calcium alginate dressings and hydrocolloid dressings. Utilizing its proprietary silver-loaded fiber spinning technology, the company successfully resolved the issue of silver ion shedding common in traditional dressings. Its safe and highly effective wound care solutions earned high acclaim from the North American medical community and led to the signing of multiple on-site cooperation agreements. Dubai WHX Medical Exhibition: As a bellwether event for the medical industry in the Middle East and North Africa (MENA) region, Roosin Medical showcased a range of dressings featuring exceptional antimicrobial, waterproof, and breathable properties—solutions specifically designed to address local clinical challenges such as high humidity and elevated infection risks. Backed by comprehensive international certifications (FDA, CE, ISO) and consistent product quality, the company rapidly established connections with buyers from Gulf Cooperation Council (GCC) nations, laying a solid foundation for further expansion into the Middle East, North Africa, and South Asia.
A Global Reputation Built on Technological Leadership and Quality
Founded in 1996, Roosin Medical is a pioneer in the field of calcium alginate medical dressings in China. The company holds 58 patents, operates the "Jiangsu Biomedical Dressing Engineering Research Center," and invests over 10% of its revenue in research and development. Its flagship product—silver-containing calcium alginate dressing—is manufactured using fibers extracted from marine brown algae and advanced silver-loading spinning technology. Upon absorbing wound exudate, the product forms a gel that prevents adherence to the wound while maintaining a moist healing environment; offering antimicrobial efficacy for up to seven days, it has become a benchmark product in the global high-end wound care sector.